Coverage of genetic technologies under national health reform.
This article examines the extent to which the technologies expected to emerge from genetic research are likely to be covered under Government-mandated health insurance programs such as those being proposed by advocates of national health reform. Genetic technologies are divided into three broad categories; genetic information services, including screening, testing, and counseling; experimental technologies; and gene therapy. This article concludes that coverage of these technologies under national health reform is uncertain. The basic benefits packages provided for in the major health reform plans are likely to provide partial coverage of experimental technologies; relatively broad coverage of information services; and varying coverage of gene therapies, on the basis of an evaluation of their costs, benefits, and the degree to which they raise objections on political and religious grounds. Genetic services that are not included in the basic benefits package will be available only to those who can purchase supplemental insurance or to those who can purchase the services with personal funds. The resulting multitiered system of access to genetic services raises serious questions of fairness.
Law-Medicine Center, Case Western Reserve University, Cleveland, OH 44106.
M J
MJ
Mehlman
J R
JR
Botkin
A
A
Scarrow
A
A
Woodhall
J
J
Kass
E
E
Siebenschuh
D035082:Federal Government; D030342:Genetic Diseases, Inborn; D036281:Genetic Research; D015316:Genetic Therapy / Q000191:economics; D005826:Genetics, Medical / Q000191:economics*; D033161:Government Regulation; D018166:Health Care Reform; D006801:Humans; D007348:Insurance, Health / Q000592:standards*; D036302:Therapeutic Human Experimentation; D014481:United States